Comparative Effectiveness of Several Second-Line Dual Oral Antidiabetic Combinations in Reducing Cardiovascular Events in Type 2 Diabetes-A Nationwide Study

被引：0
|
作者：
Chang, Chia-Hsuin
Chang, Yi-Cheng
Lin, Jou-Wei
Chen, Shu-Ting
Lai, Mei-Shu
Chuang, Lee-Ming
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2408-PO
引用
收藏
页码：A611 / A611
页数：1
相关论文
共 50 条
  • [1] Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study
    Chang, Y. -C.
    Chuang, L. -M.
    Lin, J. -W.
    Chen, S. -T.
    Lai, M. -S.
    Chang, C. -H.
    DIABETIC MEDICINE, 2015, 32 (11) : 1460 - 1469
  • [2] Adherence to newer second-line oral antidiabetic drugs among people with type 2 diabetes-A systematic review
    Holdt-Caspersen, Nynne Sophie
    Dethlefsen, Claus
    Vestergaard, Peter
    Hejlesen, Ole
    Hangaard, Stine
    Jensen, Morten Hasselstrom
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2024, 12 (02):
  • [3] Association of Second-line Antidiabetic Medications With Cardiovascular Events Among Insured Adults With Type 2 Diabetes
    O'Brien, Matthew J.
    Karam, Susan L.
    Wallia, Amisha
    Kang, Raymond H.
    Cooper, Andrew J.
    Lancki, Nicola
    Moran, Margaret R.
    Liss, David T.
    Prospect, Theodore A.
    Ackermann, Ronald T.
    JAMA NETWORK OPEN, 2018, 1 (08)
  • [4] Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study
    Wang, Huan
    Cordiner, Ruth L. M.
    Huang, Yu
    Donnelly, Louise
    Hapca, Simona
    Collier, Andrew
    McKnight, John J.
    Kennon, Brian R.
    Gibb, Fraser R.
    McKeigue, Paul
    Wild, Sarah
    Colhoun, Helen
    Chalmers, John
    Petrie, John
    Sattar, Naveed
    MacDonald, Thomas
    McCrimmon, Rory
    Morales, Daniel
    Pearson, Ewan
    DIABETES CARE, 2023, 46 (05) : 967 - 977
  • [5] Type 2 diabetes: second-line antidiabetic therapy in early pregnancy
    Clauss, Maria
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2024, 228 (02): : 119 - 119
  • [6] Outcomes of second-line oral antidiabetic drugs in persons with young-onset type 2 diabetes
    Yen, Fu-Shun
    Wei, James Cheng-Chung
    Liu, Jia-Sin
    Hsu, Chih-Cheng
    Hwu, Chii-Min
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 177
  • [7] Comparative Effectiveness of Second-Line Initiation of Basal Insulin Therapy vs. Oral Antidiabetic Drugs Added to Metformin among Patients with Type 2 Diabetes in Taiwan
    Chen, Pin-Hao
    Kuo, Shihchen
    Ou, Huang-Tz
    DIABETES, 2019, 68
  • [8] Cost-Effectiveness of Newer Antidiabetic Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review
    Jiejin Zhu
    Ying Zhou
    Qingyu Li
    Gang Wang
    Advances in Therapy, 2023, 40 : 4216 - 4235
  • [9] Cost-Effectiveness of Newer Antidiabetic Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review
    Zhu, Jiejin
    Zhou, Ying
    Li, Qingyu
    Wang, Gang
    ADVANCES IN THERAPY, 2023, 40 (10) : 4216 - 4235
  • [10] Investigating ethnic Differences in the Comparative Effectiveness of Classes of Second-Line Antidiabetic Medications at Preventing Cardiovascular Outcomes
    Harley, Mia S.
    Rentsch, Christopher T.
    Mathur, Rohini
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 363 - 363
12345